Janice Chen Topic

Janice Chen is the co-founder, CSO and President of Research at Mammoth Biosciences, a biotechnology company based in the San Francisco Bay Area that is harnessing the diversity of nature to develop in vivo gene editing therapies. Through its AI enabled discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Janice received her PhD from the lab of Nobel Laureate Jennifer Doudna, also a fellow Mammoth co-founder, at the University of California, Berkeley, where she investigated mechanisms of CRISPR-Cas proteins and is an inventor of several CRISPR-based technologies. Janice's work has been recognized by several organizations, including Forbes 30 Under 30 in Healthcare, Endpoints Top 20 Women in Biopharma, and MIT Technology Review 35 Innovators Under 35.